Astera Labs, Inc. (ALAB)
Official siteTECHNOLOGY • SEMICONDUCTORS • NASDAQ
Market Cap: $38.77B
Last updated: Nov 17, 2026 at 11:05 AM ET
Astera Labs, Inc. (ALAB) P/E Ratio & Valuation Multiples
Astera Labs (ALAB) trades at 75.8x trailing earnings and 22.6x sales. Its forward P/E is 32.7x. The median P/E across 11 similar companies is 32.8x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 131.8% higher over the next year. Its free cash flow yield is 1.0%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 75.8x |
| Forward P/E | 32.7x |
| Price to sales | 22.6x |
| Price to book | 17.6x |
| EV/EBITDA | 85.9x |
| Price to FCF | 102.2x |
|---|---|
| EV/FCF | 101.6x |
| PEG | N/A |
| FCF yield | 1.0% |
As of Nov 17, 2026
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ALAB
What is ALAB's forward P/E ratio?
Astera Labs has a forward P/E ratio of 32.7x.
Is ALAB stock overvalued?
GNG's valuation label for ALAB is Undervalued. Its P/E of 75.8x compares with a median of 32.8x across 11 similar companies.
What is ALAB's price to sales ratio?
Astera Labs has a price to sales ratio of 22.6x.
ALAB pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors